FDA Approves Wyeth's Pristiq
Desvenlafaxine is an antidepressant (serotonin-norepinephrine reuptake inhibitor type-SNRI) used in the treatment of depression.
It works by restoring the balance of natural substances (neurotransmitters such as serotonin and norepinephrine) in the brain. Desvenlafaxine may improve your mood, feelings of well-being, and energy level.
Pristiq is a medication licensed for the treatment of depression. By blocking the reuptake of serotonin and norepinephrine in the brain, the drug can help improve symptoms. Pristiq, which is available by prescription only, comes in the form of an extended-release tablet, and is generally taken once daily. Potential side effects include dizziness, insomnia, headaches, and nausea.
Pristiq is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by restoring the balance of certain natural substances in the brain (serotonin and norepinephrine), which helps to improve certain mood problems.
Pristiq is used to treat major depressive disorder.
Even with the numerous antidepressants out there, any new drug that gets approved by FDA generates a huge amount of interest and expectation.
Pristiq from Wyeth is the newest antidepressant approved by the Food and Drug Administration (FDA) on Friday. It is the successor to the top-selling Effexor, the extended-release depression drug from Wyeth. Pristiq is expected to hit the market in a few months.
Pristiq is a once-daily serotonin-norepinephrine reuptake inhibitor to treat adult patients suffering from major depressive disorder (MDD.)